Management Team


SEVER’s Core Strength

The core strength of SEVER Life Sciences lies in the range of what our companies offer to patients across the world. Created as a holding company in 2019, SEVER brings together four diverse but complementary companies, each with their own expertise and specialist focus. As a result, SEVER oversees an unrivalled and uniquely successful range of products, services and technologies.

The four companies – Amring USA, Izvarino, Nordic Pharma and Pharma Services – are all united by a common purpose: a concern for patients. These companies provide new drugs for unmet medical needs; they supply consistent, relevant and high-quality generic drugs; and they develop, license and manufacture pharmaceutical products.

SEVER Life Sciences has therefore been created to fully exploit this diversity and to significantly increase overall value and benefits for customers, shareholders and – above all – patients.

Sean Davis

Chief Executive Officer

Executive team

The Sever executive team is constituted of a group of seasoned managers with relevant experience in their respective domains and markets